Bhalchandra K Vaidy, and Sandeep Bijamwar in this article describes applications of lipases in pharma and fine chemical industry
The past decade has witnessed a heightened interest in exploring potential of enzymes for industrial organic synthesis. Chemically enzymes are proteins and functionally they are catalysts of biological systems (biocatalysts). Being catalysts, enzymes accelerate the rate of reaction by decreasing the energy of activation.
The high selectivity and specificity of enzymes make them valuable catalysts especially for synthesis of pharmaceuticals and fine chemicals, where the demand for enantiomerically pure molecules is continuously increasing .
Advantages of enzymes:
Classification of enzymes
Enzymes catalyse enormous range of reactions. They are increasingly found to transform almost any reaction of organic chemistry. According to the report of the first Enzyme Commission in 1961, enzymes are classified into six classes depending upon the type of reaction they catalyse . The six classes of enzyme and corresponding type of reactions are summarised in Table 1.
Among the six classes of enzymes, hydrolases have a major share in industrial biotransformations particularly in resolution of racemic compounds and in asymmetric synthesis of enantiopure chiral compounds. Hydrolases are relatively stable enzymes and their catalysis do not require co-factor. One of the most extensively utilised enzymes of hydrolase class is lipase.
Lipases (triacylglycerol ester hydrolase, EC 22.214.171.124) are important enzymes in biological systems, where they catalyze the hydrolysis of triacylglycerol to glycerol and fatty acids. Besides their natural substrates, lipases are capable of catalysing a wide range of non-natural chemical compounds.
Depending on the nature of substrate and reaction conditions, lipases catalyze a wide range of enantio- and regio-selective reactions such as hydrolysis, esterifications, transesterifications, interesterification, aminolysis and ammoniolysis (Fig. 2). Due to their catalytic versatility, lipases have emerged as a unique industrial biocatalyst in pharmaceutical, fine chemical, food and flavouring and recently in cosmetics and perfumery industries .
Lipases are ubiquitous in nature and are produced by several plants, higher animals, and microorganisms. Microorganisms have shorter life-span, are easy to cultivate by fermentation and easy to manipulate genetically. Hence, most of commercial lipases are from microbial sources.
We at ‘Advanced Enzymes’ manufacture and export enzymes to the various applications for last 50 years. Our lipases are robust biocatalysts useful for industrial organic syntheses of pharmaceutical building blocks and fine chemicals. Our lipases are available in soluble and immobilised preparations. The immobilised lipases are support-bound and therefore can be recovered from the reaction mixture and can be reused for repetitive biotransformation cycles.
Lipases for pharma and fine chemical industry
The role of chirality in efficacy and safety of drugs has been thoroughly identified and implicated globally by pharma companies as well as concerned regulatory agencies. As a consequence, the production of single enantiomers of active pharmaceutical intermediates (APIs) has become increasingly important in pharma industries.
Besides pharma, the ‘chirality’ is receiving attention particularly in agrochemical, perfumery, flavour and dye industries . Being stereo-selective, lipases play a significant role in production of enantiopure intermediates. Representative examples of APIs and fine chemicals which are synthesised by lipase catalysed biotransformations are listed in Table 2.
Enzymes (biocatalysts) are increasingly used in industrial organic synthesis. Lipases are eco-friendly, stereo-selective biocatalysts. They exhibit broad substrate specificity and catalytic versatility.
Moreover, lipase catalysed biotransformations are simple, do not require co-factor and are easy to scale-up. As a result, lipases have emerged as important industrial biocatalysts especially for production of enantiopure drug intermediates and fine chemicals.
Table 1: Classification of Enzymes
|Number||Enzyme class (EC)||Type of reaction|
|Oxidoreductases||Catalyse oxidation-reduction reactions|
|Transferases||Catalyse transfer of specific groups such as methyl,
amino, acyl, glycosyl or phosphate from one substance to another
|Hydrolases||Catalyse hydrolytic cleavage of C-C, C-O,
C-N and other bonds
|Lyases||Catalyse cleavage of C-C, C-O, C-N and other bonds by
|Isomerases||Catalyse isomerization reactions|
|Ligases||Catalyse joining of two molecules|
The current trends of industrial manufacturing viz. ‘green synthesis’ and ‘sustainable development’ suggest that the commercial utilisation of lipases in pharma and fine chemical industries will continue to expand in years to come.
Furthermore, the recent technological developments in large-scale DNA sequencing, protein expression systems and enzyme engineering methods will foster the industrial utilisation of lipases, and also other enzymes by in large.
1. Bommarius, A.S.; Riebel, B.R. Biocatalysis: Fundamentals and applications. Wiley VCH, Weinheim, 2004.
2. Vaidya, B.K.; Ingavle, G.C.; Ponrathnam, S.; Kulkarni, B.D.; Nene, S. Immobilization of Candida rugosa lipase on poly(allyl glycidyl ether-coethylene glycol dimethacrylate) macroporous polymer particles. Bioresource Technol., 99 (2008) 3623-3629.
3. Caner, H.; Groner, E.; Levy, L.; Agranat, I. Trends in the development of chiral drugs. Drug Discov. Today, 9 (2004) 105-110.
4. Anderson, E.M.; Larsson, K.M.; Kirk, O. One biocatalyst-many applications: The use of Candida antarctica B-lipase in organic synthesis. Biocatal. Biotransform., 16 (1998) 181-204.
5. Fernandez-Lafuente, R. Lipase from Thermomyces lanuginosus: Uses and prospects as an industrial biocatalyst. J. Mol. Catal. B: Enzym., 62 (2010) 197-212.
6. Liljeblad, A.; Kallinen, A.; Kanerva L.T. Biocatalysis in the preparation of the statin side chain. Curr. Org. Chem., 6 (2009) 362-379.
7. Patel, R.N. Synthesis of chiral pharmaceutical intermediates by biocatalysis. Coord. Chem. Rev., 252 (2008) 659-701.
8. Ghanem, A. Trends in lipase-catalyzed asymmetric access to enantiomerically pure/enriched compounds. Tetrahedron, 63 (2007) 1721-1754.